US agency selects UQ for ‘one of the world’s most ambitious biomanufacturing programs'
A United States Government agency has selected University of Queensland researchers to develop technology for personalized RNA medicines to be produced in hospitals, allowing lifesaving treatments to reach patients within days.
Read original article on The Medical News →Related news
-
Destruction of water systems directly threatens global public health
United Kingdom
-
Dehydration, UTIs and cognitive health: Getting enough to drink is complicated for people with brain disorders
United Kingdom
-
Young cancer survivors face critical gaps in follow-up care
United Kingdom
-
How microplastics and bacteria interact to drive antibiotic resistance
United Kingdom
-
Clinical trials generate promising results for improving kidney health
United Kingdom
-
How long until wearable brain‑computer interfaces become mainstream?
United Kingdom
-
Half-matched bone marrow transplants show high survival in young aplastic anemia patients
United Kingdom
-
Community health workers help patients piece their lives back together
United Kingdom